← back to search

D M Goldenberg

Immunomedics (United States) · US
Area of research
Radiology, Nuclear Medicine and Imaging · Molecular Biology
Research interest
Research interests include Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research, Glycosylation and Glycoproteins Research, and Cancer Research and Treatments.
h-index
31
citations
2,680
works
134
NIH funding
—
primary concept
Medicine
email
dgoldenberg@pennstatehealth.psu.edu

Recent publications

LBA17 ASCENT: A randomized phase III study of sacituzumab govitecan (SG) vs treatment of physician’s choice (TPC) in patients (pts) with previously treated metastatic triple-negative breast cancer (mTNBC)
Annals of Oncology 2020cited by 64position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Kevin Punie · Ziekenhuisnetwerk Antwerpen Stuivenberg1 papers (2020–2020)Aditya Bardia · Comprehensive Blood & Cancer Center1 papers (2020–2020)Adam Brufsky · UPMC Hillman Cancer Center1 papers (2020–2020)Javier Cortés · Universidade Nova de Lisboa1 papers (2020–2020)Lisa A. Carey · University of North Carolina at Chapel Hill1 papers (2020–2020)Mafalda Oliveira · Hospital Garcia de Orta1 papers (2020–2020)Kevin Kalinsky · Emory Healthcare1 papers (2020–2020)Véronique Dièras · Centre Eugène Marquis1 papers (2020–2020)Loretta M. Itri · BioScience Laboratories (United States)1 papers (2020–2020)Sara A. Hurvitz · University of Washington Applied Physics Laboratory1 papers (2020–2020)Sara M. Tolaney · Medidata (United States)1 papers (2020–2020)Joyce O’Shaughnessy · Baylor University Medical Center1 papers (2020–2020)L. Gianni · Fondazione Michelangelo1 papers (2020–2020)Martine Piccart · Tecnológico de Monterrey1 papers (2020–2020)Sibylle Loibl · Breast Center1 papers (2020–2020)Hope S. Rugo · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2020–2020)Q. Hong · Bạch Mai Hospital1 papers (2020–2020)Martin Olivo · Immunomedics (United States)1 papers (2020–2020)Delphine Loirat · Institut Curie1 papers (2020–2020)